世界の淋菌感染症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Neisseria Gonorrhoeae Infections Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4560
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、淋菌感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（クリブロスタチン-6、ダルババンシン、デビオ-1453、メシル酸ゲポチダシン、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・淋菌感染症治療の市場動向
・企業の競争状況、市場シェア
・淋菌感染症治療の種類別市場規模と予測2016-2027（クリブロスタチン-6、ダルババンシン、デビオ-1453、メシル酸ゲポチダシン、その他）
・淋菌感染症治療の用途別市場規模と予測2016-2027（クリニック、病院、その他）
・淋菌感染症治療の北米市場規模2016-2027（アメリカ、カナダ）
・淋菌感染症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・淋菌感染症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・淋菌感染症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・淋菌感染症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Allergan Plc、BioDiem Ltd、Biolytics Pharma、Debiopharm International SA、F. Hoffmann-La Roche Ltd.、GlaxoSmithKline Plc、Merck & Co., Inc.、Paratek Pharmaceuticals, Inc.、Recce Pty Ltd、Redx Pharma Plc、Sarepta Therapeutics, Inc.、Sumitomo Dainippon Pharma Co., Ltd.）
・結論

Market Analysis and Insights: Global Neisseria Gonorrhoeae Infections Treatment Market
The global Neisseria Gonorrhoeae Infections Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neisseria Gonorrhoeae Infections Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neisseria Gonorrhoeae Infections Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neisseria Gonorrhoeae Infections Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neisseria Gonorrhoeae Infections Treatment market.

Global Neisseria Gonorrhoeae Infections Treatment Scope and Market Size
Neisseria Gonorrhoeae Infections Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neisseria Gonorrhoeae Infections Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Cribrostatin-6
Dalbavancin
Debio-1453
Gepotidacin Mesylate
Others

Segment by Application
Clinic
Hospital
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Allergan Plc
BioDiem Ltd
Biolytics Pharma
Debiopharm International SA
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc
Merck & Co., Inc.
Paratek Pharmaceuticals, Inc.
Recce Pty Ltd
Redx Pharma Plc
Sarepta Therapeutics, Inc.
Sumitomo Dainippon Pharma Co., Ltd.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neisseria Gonorrhoeae Infections Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cribrostatin-6
1.2.3 Dalbavancin
1.2.4 Debio-1453
1.2.5 Gepotidacin Mesylate
1.2.6 Others
1.3 Market by Application
1.3.1 Global Neisseria Gonorrhoeae Infections Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Neisseria Gonorrhoeae Infections Treatment Market Perspective (2016-2027)
2.2 Neisseria Gonorrhoeae Infections Treatment Growth Trends by Regions
2.2.1 Neisseria Gonorrhoeae Infections Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Neisseria Gonorrhoeae Infections Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Neisseria Gonorrhoeae Infections Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Neisseria Gonorrhoeae Infections Treatment Industry Dynamic
2.3.1 Neisseria Gonorrhoeae Infections Treatment Market Trends
2.3.2 Neisseria Gonorrhoeae Infections Treatment Market Drivers
2.3.3 Neisseria Gonorrhoeae Infections Treatment Market Challenges
2.3.4 Neisseria Gonorrhoeae Infections Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Neisseria Gonorrhoeae Infections Treatment Players by Revenue
3.1.1 Global Top Neisseria Gonorrhoeae Infections Treatment Players by Revenue (2016-2021)
3.1.2 Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Neisseria Gonorrhoeae Infections Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Neisseria Gonorrhoeae Infections Treatment Revenue
3.4 Global Neisseria Gonorrhoeae Infections Treatment Market Concentration Ratio
3.4.1 Global Neisseria Gonorrhoeae Infections Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neisseria Gonorrhoeae Infections Treatment Revenue in 2020
3.5 Neisseria Gonorrhoeae Infections Treatment Key Players Head office and Area Served
3.6 Key Players Neisseria Gonorrhoeae Infections Treatment Product Solution and Service
3.7 Date of Enter into Neisseria Gonorrhoeae Infections Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Neisseria Gonorrhoeae Infections Treatment Breakdown Data by Type
4.1 Global Neisseria Gonorrhoeae Infections Treatment Historic Market Size by Type (2016-2021)
4.2 Global Neisseria Gonorrhoeae Infections Treatment Forecasted Market Size by Type (2022-2027)

5 Neisseria Gonorrhoeae Infections Treatment Breakdown Data by Application
5.1 Global Neisseria Gonorrhoeae Infections Treatment Historic Market Size by Application (2016-2021)
5.2 Global Neisseria Gonorrhoeae Infections Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Neisseria Gonorrhoeae Infections Treatment Market Size (2016-2027)
6.2 North America Neisseria Gonorrhoeae Infections Treatment Market Size by Type
6.2.1 North America Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2021)
6.2.2 North America Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2022-2027)
6.2.3 North America Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2027)
6.3 North America Neisseria Gonorrhoeae Infections Treatment Market Size by Application
6.3.1 North America Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2021)
6.3.2 North America Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2022-2027)
6.3.3 North America Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2027)
6.4 North America Neisseria Gonorrhoeae Infections Treatment Market Size by Country
6.4.1 North America Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2016-2021)
6.4.2 North America Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Neisseria Gonorrhoeae Infections Treatment Market Size (2016-2027)
7.2 Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Type
7.2.1 Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2021)
7.2.2 Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2022-2027)
7.2.3 Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2027)
7.3 Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Application
7.3.1 Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2021)
7.3.2 Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2022-2027)
7.3.3 Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2027)
7.4 Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Country
7.4.1 Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2016-2021)
7.4.2 Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size (2016-2027)
8.2 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Type
8.2.1 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Application
8.3.1 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Region
8.4.1 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size (2016-2027)
9.2 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Type
9.2.1 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2027)
9.3 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Application
9.3.1 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2027)
9.4 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Country
9.4.1 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size (2016-2027)
10.2 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Type
10.2.1 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Application
10.3.1 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Country
10.4.1 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Allergan Plc
11.1.1 Allergan Plc Company Details
11.1.2 Allergan Plc Business Overview
11.1.3 Allergan Plc Neisseria Gonorrhoeae Infections Treatment Introduction
11.1.4 Allergan Plc Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021)
11.1.5 Allergan Plc Recent Development
11.2 BioDiem Ltd
11.2.1 BioDiem Ltd Company Details
11.2.2 BioDiem Ltd Business Overview
11.2.3 BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Introduction
11.2.4 BioDiem Ltd Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021)
11.2.5 BioDiem Ltd Recent Development
11.3 Biolytics Pharma
11.3.1 Biolytics Pharma Company Details
11.3.2 Biolytics Pharma Business Overview
11.3.3 Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Introduction
11.3.4 Biolytics Pharma Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021)
11.3.5 Biolytics Pharma Recent Development
11.4 Debiopharm International SA
11.4.1 Debiopharm International SA Company Details
11.4.2 Debiopharm International SA Business Overview
11.4.3 Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Introduction
11.4.4 Debiopharm International SA Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021)
11.4.5 Debiopharm International SA Recent Development
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Details
11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Introduction
11.5.4 F. Hoffmann-La Roche Ltd. Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021)
11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
11.6 GlaxoSmithKline Plc
11.6.1 GlaxoSmithKline Plc Company Details
11.6.2 GlaxoSmithKline Plc Business Overview
11.6.3 GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Introduction
11.6.4 GlaxoSmithKline Plc Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021)
11.6.5 GlaxoSmithKline Plc Recent Development
11.7 Merck & Co., Inc.
11.7.1 Merck & Co., Inc. Company Details
11.7.2 Merck & Co., Inc. Business Overview
11.7.3 Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Introduction
11.7.4 Merck & Co., Inc. Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021)
11.7.5 Merck & Co., Inc. Recent Development
11.8 Paratek Pharmaceuticals, Inc.
11.8.1 Paratek Pharmaceuticals, Inc. Company Details
11.8.2 Paratek Pharmaceuticals, Inc. Business Overview
11.8.3 Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Introduction
11.8.4 Paratek Pharmaceuticals, Inc. Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021)
11.8.5 Paratek Pharmaceuticals, Inc. Recent Development
11.9 Recce Pty Ltd
11.9.1 Recce Pty Ltd Company Details
11.9.2 Recce Pty Ltd Business Overview
11.9.3 Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Introduction
11.9.4 Recce Pty Ltd Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021)
11.9.5 Recce Pty Ltd Recent Development
11.10 Redx Pharma Plc
11.10.1 Redx Pharma Plc Company Details
11.10.2 Redx Pharma Plc Business Overview
11.10.3 Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Introduction
11.10.4 Redx Pharma Plc Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021)
11.10.5 Redx Pharma Plc Recent Development
11.11 Sarepta Therapeutics, Inc.
11.11.1 Sarepta Therapeutics, Inc. Company Details
11.11.2 Sarepta Therapeutics, Inc. Business Overview
11.11.3 Sarepta Therapeutics, Inc. Neisseria Gonorrhoeae Infections Treatment Introduction
11.11.4 Sarepta Therapeutics, Inc. Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021)
11.11.5 Sarepta Therapeutics, Inc. Recent Development
11.12 Sumitomo Dainippon Pharma Co., Ltd.
11.12.1 Sumitomo Dainippon Pharma Co., Ltd. Company Details
11.12.2 Sumitomo Dainippon Pharma Co., Ltd. Business Overview
11.12.3 Sumitomo Dainippon Pharma Co., Ltd. Neisseria Gonorrhoeae Infections Treatment Introduction
11.12.4 Sumitomo Dainippon Pharma Co., Ltd. Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021)
11.12.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Neisseria Gonorrhoeae Infections Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cribrostatin-6
Table 3. Key Players of Dalbavancin
Table 4. Key Players of Debio-1453
Table 5. Key Players of Gepotidacin Mesylate
Table 6. Key Players of Others
Table 7. Global Neisseria Gonorrhoeae Infections Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Neisseria Gonorrhoeae Infections Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Neisseria Gonorrhoeae Infections Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Neisseria Gonorrhoeae Infections Treatment Market Share by Regions (2016-2021)
Table 11. Global Neisseria Gonorrhoeae Infections Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Neisseria Gonorrhoeae Infections Treatment Market Share by Regions (2022-2027)
Table 13. Neisseria Gonorrhoeae Infections Treatment Market Trends
Table 14. Neisseria Gonorrhoeae Infections Treatment Market Drivers
Table 15. Neisseria Gonorrhoeae Infections Treatment Market Challenges
Table 16. Neisseria Gonorrhoeae Infections Treatment Market Restraints
Table 17. Global Neisseria Gonorrhoeae Infections Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Neisseria Gonorrhoeae Infections Treatment Market Share by Players (2016-2021)
Table 19. Global Top Neisseria Gonorrhoeae Infections Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neisseria Gonorrhoeae Infections Treatment as of 2020)
Table 20. Ranking of Global Top Neisseria Gonorrhoeae Infections Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Neisseria Gonorrhoeae Infections Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Neisseria Gonorrhoeae Infections Treatment Product Solution and Service
Table 24. Date of Enter into Neisseria Gonorrhoeae Infections Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Neisseria Gonorrhoeae Infections Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Neisseria Gonorrhoeae Infections Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Neisseria Gonorrhoeae Infections Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Allergan Plc Company Details
Table 65. Allergan Plc Business Overview
Table 66. Allergan Plc Neisseria Gonorrhoeae Infections Treatment Product
Table 67. Allergan Plc Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) & (US$ Million)
Table 68. Allergan Plc Recent Development
Table 69. BioDiem Ltd Company Details
Table 70. BioDiem Ltd Business Overview
Table 71. BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Product
Table 72. BioDiem Ltd Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) & (US$ Million)
Table 73. BioDiem Ltd Recent Development
Table 74. Biolytics Pharma Company Details
Table 75. Biolytics Pharma Business Overview
Table 76. Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Product
Table 77. Biolytics Pharma Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) & (US$ Million)
Table 78. Biolytics Pharma Recent Development
Table 79. Debiopharm International SA Company Details
Table 80. Debiopharm International SA Business Overview
Table 81. Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Product
Table 82. Debiopharm International SA Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) & (US$ Million)
Table 83. Debiopharm International SA Recent Development
Table 84. F. Hoffmann-La Roche Ltd. Company Details
Table 85. F. Hoffmann-La Roche Ltd. Business Overview
Table 86. F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Product
Table 87. F. Hoffmann-La Roche Ltd. Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) & (US$ Million)
Table 88. F. Hoffmann-La Roche Ltd. Recent Development
Table 89. GlaxoSmithKline Plc Company Details
Table 90. GlaxoSmithKline Plc Business Overview
Table 91. GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Product
Table 92. GlaxoSmithKline Plc Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) & (US$ Million)
Table 93. GlaxoSmithKline Plc Recent Development
Table 94. Merck & Co., Inc. Company Details
Table 95. Merck & Co., Inc. Business Overview
Table 96. Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Product
Table 97. Merck & Co., Inc. Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) & (US$ Million)
Table 98. Merck & Co., Inc. Recent Development
Table 99. Paratek Pharmaceuticals, Inc. Company Details
Table 100. Paratek Pharmaceuticals, Inc. Business Overview
Table 101. Paratek Pharmaceuticals, Inc. Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) & (US$ Million)
Table 102. Paratek Pharmaceuticals, Inc. Recent Development
Table 103. Recce Pty Ltd Company Details
Table 104. Recce Pty Ltd Business Overview
Table 105. Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Product
Table 106. Recce Pty Ltd Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) & (US$ Million)
Table 107. Recce Pty Ltd Recent Development
Table 108. Redx Pharma Plc Company Details
Table 109. Redx Pharma Plc Business Overview
Table 110. Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Product
Table 111. Redx Pharma Plc Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) & (US$ Million)
Table 112. Redx Pharma Plc Recent Development
Table 113. Sarepta Therapeutics, Inc. Company Details
Table 114. Sarepta Therapeutics, Inc. Business Overview
Table 115. Sarepta Therapeutics, Inc. Neisseria Gonorrhoeae Infections Treatment Product
Table 116. Sarepta Therapeutics, Inc. Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) & (US$ Million)
Table 117. Sarepta Therapeutics, Inc. Recent Development
Table 118. Sumitomo Dainippon Pharma Co., Ltd. Company Details
Table 119. Sumitomo Dainippon Pharma Co., Ltd. Business Overview
Table 120. Sumitomo Dainippon Pharma Co., Ltd. Neisseria Gonorrhoeae Infections Treatment Product
Table 121. Sumitomo Dainippon Pharma Co., Ltd. Revenue in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021) & (US$ Million)
Table 122. Sumitomo Dainippon Pharma Co., Ltd. Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neisseria Gonorrhoeae Infections Treatment Market Share by Type: 2020 VS 2027
Figure 2. Cribrostatin-6 Features
Figure 3. Dalbavancin Features
Figure 4. Debio-1453 Features
Figure 5. Gepotidacin Mesylate Features
Figure 6. Others Features
Figure 7. Global Neisseria Gonorrhoeae Infections Treatment Market Share by Application: 2020 VS 2027
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Others Case Studies
Figure 11. Neisseria Gonorrhoeae Infections Treatment Report Years Considered
Figure 12. Global Neisseria Gonorrhoeae Infections Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Neisseria Gonorrhoeae Infections Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Neisseria Gonorrhoeae Infections Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Neisseria Gonorrhoeae Infections Treatment Market Share by Regions (2022-2027)
Figure 16. Global Neisseria Gonorrhoeae Infections Treatment Market Share by Players in 2020
Figure 17. Global Top Neisseria Gonorrhoeae Infections Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neisseria Gonorrhoeae Infections Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Neisseria Gonorrhoeae Infections Treatment Revenue in 2020
Figure 19. Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Neisseria Gonorrhoeae Infections Treatment Market Share by Type (2016-2027)
Figure 23. North America Neisseria Gonorrhoeae Infections Treatment Market Share by Application (2016-2027)
Figure 24. North America Neisseria Gonorrhoeae Infections Treatment Market Share by Country (2016-2027)
Figure 25. United States Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Neisseria Gonorrhoeae Infections Treatment Market Share by Type (2016-2027)
Figure 29. Europe Neisseria Gonorrhoeae Infections Treatment Market Share by Application (2016-2027)
Figure 30. Europe Neisseria Gonorrhoeae Infections Treatment Market Share by Country (2016-2027)
Figure 31. Germany Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Neisseria Gonorrhoeae Infections Treatment Market Share by Region (2016-2027)
Figure 41. China Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Neisseria Gonorrhoeae Infections Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Neisseria Gonorrhoeae Infections Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Neisseria Gonorrhoeae Infections Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Neisseria Gonorrhoeae Infections Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Neisseria Gonorrhoeae Infections Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Allergan Plc Revenue Growth Rate in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021)
Figure 61. BioDiem Ltd Revenue Growth Rate in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021)
Figure 62. Biolytics Pharma Revenue Growth Rate in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021)
Figure 63. Debiopharm International SA Revenue Growth Rate in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021)
Figure 64. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021)
Figure 65. GlaxoSmithKline Plc Revenue Growth Rate in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021)
Figure 66. Merck & Co., Inc. Revenue Growth Rate in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021)
Figure 67. Paratek Pharmaceuticals, Inc. Revenue Growth Rate in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021)
Figure 68. Recce Pty Ltd Revenue Growth Rate in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021)
Figure 69. Redx Pharma Plc Revenue Growth Rate in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021)
Figure 70. Sarepta Therapeutics, Inc. Revenue Growth Rate in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021)
Figure 71. Sumitomo Dainippon Pharma Co., Ltd. Revenue Growth Rate in Neisseria Gonorrhoeae Infections Treatment Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

以下、関連資料のご紹介

淋菌感染症治療のグローバル市場調査 2019年

Global Neisseria Gonorrhoeae Infections Treatment Market Professional Survey Report 2019
QYR9NV08862 2019年11月14日 111Pages
※本調査レポートは、淋菌感染症治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、クリブロスタチン-6、ダルババンシン、デビオ-1453、メシル酸ゲポチダシン...

世界の気道感染症（RTI）治療市場規模・現状・予測（2021年-2027年）

Global Respiratory Tract infections (RTIs) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4818 2021年6月 115Pages
QYResearch社発行の本調査レポートでは、気道感染症（RTI）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カプセル、錠剤）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の人工関節感染症治療市場規模・現状・予測（2021年-2027年）

Global Prosthetic Joint Infections Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4776 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、人工関節感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（フシジン酸、酢酸レファムリン、MTF-101、TNP-2092、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規...

世界の周産期感染症治療市場規模・現状・予測（2021年-2027年）

Global Perinatal Infections Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4682 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、周産期感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、抗ウイルス剤）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の急性細菌性皮膚＆皮膚組織感染症（ABSSSI）治療市場規模・現状・予測（2021年-2027年）

Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3756 2021年6月 127Pages
QYResearch社発行の本調査レポートでは、急性細菌性皮膚＆皮膚組織感染症（ABSSSI）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（デラフロキサシン、バンコマイシン、セフタロリンフォサミル、その他）、用途別市場規模（蜂巣炎、膿瘍、外科...

髄膜炎菌感染症治療薬のグローバル市場調査 2019年

Global Neisseria meningitidis Infections Drug Market Professional Survey Report 2019
QYR9NV08863 2019年11月14日 110Pages
※本調査レポートは、髄膜炎菌感染症治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、MGBBP-3、NCL-195、TP-10、その他に、用途別には、病院...

世界の髄膜炎菌感染症ワクチン市場規模・現状・予測（2021年-2027年）

Global Meningococcal Infections Vaccine Market Size, Status and Forecast 2021-2027
QFJ1-4491 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、髄膜炎菌感染症ワクチンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（4価（血清型A＆C＆W-135＆Y）、2価（血清型C＆Y）、血清型A、血清型B、血清型X）、用途別市場規模（病院、クリニック）、主...

世界のクラミジア感染症用研究＆開発パイプライン市場規模・現状・予測（2021年-2027年）

Global Chlamydia Infections Research and Development Pipeline Market Size, Status and Forecast 2021-2027
QFJ1-4002 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、クラミジア感染症用研究＆開発パイプラインの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ターゲット基準評価、作用機序基準評価、投与経路基準評価、分子タイプ基準評価）、用途別市場規模（病院、科学、その他...

世界の院内感染治療市場規模・現状・予測（2021年-2027年）

Global Hospital Acquired Infections Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-4321 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、院内感染治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗菌剤、抗ウイルス剤、抗真菌剤）、用途別市場規模（尿路感染症、人工呼吸器関連肺炎、手術部位感染症、血流感染症、その他院内感染）、主要地域別市...

世界の院内感染薬市場規模・現状・予測（2021年-2027年）

Global Hospital Acquired Infections Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4320 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、院内感染薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗菌剤、抗ウイルス剤、抗真菌剤）、用途別市場規模（尿路感染症、人工呼吸器関連肺炎、手術部位感染症、血流感染症、その他院内感染）、主要地域別市場...

淋菌感染症治療のグローバル市場調査 2019年 The global Neisseria Gonorrhoeae Infections Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Neisseria Gonorrhoeae Infections Treatment volume and value at global level, regional level and …
髄膜炎菌感染症治療薬のグローバル市場調査 2019年 The global Neisseria meningitidis Infections Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Neisseria meningitidis Infections Drug volume and value at global level, regional level and company …
世界の人工関節感染症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Prosthetic Joint Infections Treatment Market The global Prosthetic Joint Infections Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and…
世界の周産期感染症治療市場規模・現状・予測（2021年-2027年） Perinatal infections include bacterial or viral illnesses that can be passed from a mother to her baby either while the baby is still in the uterus or during the delivery process. Maternal infection can, in some cases, cause complications at birth. Market Analysis and Insights: Global Perinatal Infe…
世界の気道感染症（RTI）治療市場規模・現状・予測（2021年-2027年） Respiratory Infections Treatment can affect the sinuses, throat, airways or lungs. Market Analysis and Insights: Global Respiratory Tract infections (RTIs) Treatment Market The global Respiratory Tract infections (RTIs) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX …